HEALTH, SUBJECTIVE
Clinical trials for HEALTH, SUBJECTIVE explained in plain language.
Never miss a new study
Get alerted when new HEALTH, SUBJECTIVE trials appear
Sign up with your email to follow new studies for HEALTH, SUBJECTIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mindfulness program aims to ease teacher stress in head start classrooms
Symptom relief CompletedThis study tested a program called CHIME that teaches mindfulness and compassion to educators working in Early Head Start and Head Start programs. The goal was to see if it helps teachers feel less stressed, regulate their emotions better, and improve their overall well-being. Th…
Matched conditions: HEALTH, SUBJECTIVE
Phase: NA • Sponsor: University of Nebraska Lincoln • Aim: Symptom relief
Last updated Jun 12, 2026 12:07 UTC
-
Essential oils under the microscope: do capsules matter?
Knowledge-focused CompletedThis study looked at how frankincense, lemon, and wild orange essential oils are absorbed into the blood when taken by mouth in different capsule types. Nineteen healthy adults took part, and researchers measured oil levels in the blood over 24 hours. The goal was to see if the c…
Matched conditions: HEALTH, SUBJECTIVE
Phase: NA • Sponsor: University of Mississippi Medical Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
New tool aims to measure health in down syndrome for first time
Knowledge-focused CompletedThis study created a new tool called the Down Syndrome Health Instrument (DHI) to measure health in people with Down syndrome. Researchers worked with 758 caregivers, individuals with Down syndrome, and experts to develop and test the tool. The goal is to help doctors and researc…
Matched conditions: HEALTH, SUBJECTIVE
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
New drug ALT-BB4 passes early safety check in 290 volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and tolerance of a new drug called ALT-BB4 in 290 healthy adults. Researchers monitored for allergic reactions and injection-site side effects. The goal was to see if the drug is safe enough for further testing in patients.
Matched conditions: HEALTH, SUBJECTIVE
Phase: PHASE1 • Sponsor: Alteogen, Inc. • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC